JoinClinicalTrials.com

Results

Hot

Post your clinical trial on JoinClinicalTrials.com

Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

• Non-Invasive Spinal Cord Stimulation After Injury

  NCT03998527

  Condition:   Spinal Cord Injuries
  Intervention:   Device: Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)
  Sponsor:   University of Louisville
  Recruiting
• Study Investigating Role of Unalike Patient Positioning on PROMIS Scores

  NCT03446950

  Conditions:   Physical Activity;   Surgery;   Vaginal Hysterectomy;   Vaginal Surgery
  Intervention:   Procedure: Vaginal Surgery
  Sponsor:   University of Louisville
  Recruiting
• Metabolomic Analysis of Lung Cancer

  NCT00263731

  Conditions:   Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
  Intervention:   Other: 13-C-glucose
  Sponsors:   University of Louisville;   James Graham Brown Cancer Center
  Recruiting
• Using Media to Shift Social Norms of Violence Among Youth

  NCT02706145

  Condition:   Violence
  Intervention:   Other: Social norming campaign
  Sponsors:   University of Louisville;   Centers for Disease Control and Prevention;   Vanderbilt University
  Recruiting
• Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

  NCT03211663

  Conditions:   Knee Osteoarthritis;   Knee Arthritis;   Knee Pain Chronic
  Intervention:   Device: MOTO Medial® UKA
  Sponsor:   Medacta USA
  Recruiting
• Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

  NCT00443274

  Condition:   Breast Implant
  Interventions:   Other: NBIR Placeholder;   Device: 410 Arm;   Device: BIFs
  Sponsor:   Allergan
  Recruiting
• Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

  NCT03673462

  Condition:   Healthy Volunteers (Meningococcal Infection)
  Interventions:   Biological: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine);   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®);   Biological: Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine;   Biological: Varicella Virus Vaccine
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants

  NCT03621670

  Condition:   Infections, Meningococcal
  Interventions:   Biological: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ);   Biological: Prevnar13;   Biological: Pediarix;   Biological: Hiberix;   Biological: Rotarix;   Biological: M-M-R II;   Biological: Varivax;   Biological: Placebo (saline water)
  Sponsor:   GlaxoSmithKline
  Recruiting
• Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

  NCT03636906

  Condition:   Respiratory Syncytial Virus Infections
  Interventions:   Biological: Respiratory syncytial virus (RSV) vaccine GSK3389245A;   Biological: Bexsero;   Biological: Nimenrix;   Biological: Menveo;   Biological: Synflorix;   Drug: Placebo
  Sponsor:   GlaxoSmithKline
  Recruiting
• Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

  NCT03691610

  Condition:   Healthy Volunteers (Meningococcal Infection)
  Interventions:   Biological: Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine;   Biological: Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine;   Biological: Haemophilus b Conjugate Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine Live;   Biological: Varicella Virus Vaccine Live
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

  NCT03537508

  Condition:   Meningococcal Infections
  Interventions:   Biological: MenACYW conjugate vaccine;   Biological: MenACYW-135 conjugate vaccine;   Biological: DTaP-IPV//Hib vaccine;   Biological: Pneumococcal 13-valent conjugate vaccine;   Biological: Pentavalent rotavirus vaccine;   Biological: Hepatitis B vaccine;   Biological: Measles, mumps, rubella (MMR) vaccine;   Biological: Varicella vaccine;   Biological: Hepatitis A vaccine
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury

  NCT02731027

  Condition:   Spinal Cord Injury
  Intervention:  
  Sponsors:   Northwell Health;   United States Department of Defense;   New York State Department of Health;   University of Louisville;   Kessler Foundation;   Thomas Jefferson University;   University of British Columbia
  Recruiting
• Actis Total Hip System 2 Year Follow-up

  NCT02783274

  Conditions:   Osteoarthritis;   Traumatic Arthritis;   Rheumatoid Arthritis;   Congenital Hip Dysplasia;   Avascular Necrosis of the Femoral Head;   Acute Traumatic Fracture of the Femoral Head or Neck;   Certain Cases of Ankylosis;   Non-union of Femoral Neck Fractures;   Certain High Sub-Capital & Femoral Neck Fractures in Elderly
  Intervention:   Device: Actis Total Hip System
  Sponsor:   DePuy Orthopaedics
  Recruiting
• Alcoholic Hepatitis Network Observational Study

  NCT03850899

  Condition:   Alcoholic Hepatitis
  Intervention:  
  Sponsors:   Indiana University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  Recruiting
• Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)

  NCT01169194

  Condition:   Inflammatory Bowel Disease
  Intervention:  
  Sponsors:   Johns Hopkins University;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Baylor College of Medicine;   Rutgers, The State University of New Jersey;   University of Alabama at Birmingham;   University of Chicago;   University of Louisville;   University of Maryland, College Park;   University of North Carolina, Chapel Hill;   University of Texas Southwestern Medical Center;   Weill Medical College of Cornell University;   Virginia Commonwealth University
  Recruiting
• A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants

  NCT03979313

  Condition:   Respiratory Syncytial Virus Infections
  Interventions:   Drug: MEDI8897;   Drug: Placebo
  Sponsor:   MedImmune LLC
  Recruiting
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

  NCT03731091

  Condition:   Psoriasis Vulgaris
  Interventions:   Drug: Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%;   Drug: Enstilar® foam (LEO Pharma Inc.);   Other: Placebo of Calcipotriene/ betamethasone dipropionate topical foam
  Sponsor:   Glenmark Pharmaceuticals Ltd. India
  Recruiting
• A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

  NCT03692871

  Condition:   Pneumococcal Infections
  Interventions:   Biological: V114;   Biological: Prevnar 13™
  Sponsor:   Merck Sharp & Dohme Corp.
  Recruiting
• Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

  NCT03664739

  Condition:   Acne Vulgaris
  Interventions:   Drug: IDP-120 Gel;   Drug: IDp-120 Vehicle Gel
  Sponsor:   Bausch Health Americas, Inc.
  Recruiting
• Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

  NCT03550313

  Condition:   Pneumococcal Infections
  Interventions:   Biological: Multivalent;   Biological: Prevnar 13
  Sponsor:   Pfizer
  Recruiting
• Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)

  NCT03257436

  Condition:   Left Ventricular Dysfunction
  Intervention:   Device: CRT-D
  Sponsors:   Boston Scientific Corporation;   ICON Clinical Research
  Recruiting
• Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

  NCT02003222

  Conditions:   Acute Lymphoblastic Leukemia;   B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative;   BCR/ABL1 Fusion Protein Negative;   Untreated Adult Acute Lymphoblastic Leukemia
  Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
  Sponsors:   National Cancer Institute (NCI);   Canadian Cancer Trials Group
  Recruiting
• Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing

  NCT01833195

  Conditions:   Cardiac Transplant Failure;   Cardiac Transplant Rejection;   Heart Diseases
  Intervention:  
  Sponsor:   CareDx
  Recruiting
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  NCT01574053

  Condition:   Huntington's Disease
  Intervention:  
  Sponsor:   CHDI Foundation, Inc.
  Recruiting
• Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

  NCT00785525

  Condition:   Healthy
  Intervention:   Drug: Filgrastim
  Sponsors:   Center for International Blood and Marrow Transplant Research;   National Marrow Donor Program
  Recruiting